反応式
C(Cl)CCl.C[C:6]1[C:14]2[C:9](=[CH:10][CH:11]=[CH:12][CH:13]=2)[NH:8][C:7]=1[CH2:15]NC.Cl.[O:19]=[C:20]1[NH:29][C:28]2[N:27]=[CH:26][C:25]([CH:30]=[CH:31][C:32]([OH:34])=O)=[CH:24][C:23]=2[CH2:22][CH2:21]1.C1C=CC2N(O)N=[N:41][C:39]=2C=1.CCN(C(C)C)C(C)C>CN(C=O)C.O>[CH3:39][NH:41][C:32](=[O:34])[C:31]([CH2:15][C:7]1[NH:8][C:9]2[C:14]([CH:6]=1)=[CH:13][CH:12]=[CH:11][CH:10]=2)=[CH:30][C:25]1[CH:26]=[N:27][C:28]2[NH:29][C:20](=[O:19])[CH2:21][CH2:22][C:23]=2[CH:24]=1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
EDC (498 mg, 2.6 mmol) was added to a solution of 3-methyl-2-(methylaminomethyl)indole (348 mg, 2.0 mmol), 3-(7-oxo-5,6,7,8-tetrahydro-[1,8]naphthyridin-3-yl)-acrylic acid hydrochloride (533 mg, 2.1 mmol), HOBT.H2O (270 mg, 2.0 mmol) and DIPEA (1.04 mL, 6 mmol) in DMF (5 mL). After stirring overnight, the mixture was slowly diluted with water (50 mL). The resulting precipitate was collected by filtration washed with water and dried. The precipitate was suspended in MeOH (10 mL), stirred for 60 hours, filtered and dried to afford title compound (203 mg, 27%). 1H NMR (300 MHz, DMSO-d6, 8): 10.77 and 10.58 (rotamers, 2s, br, 1H), 10.64 (s, br, 1H), 8.37 (d, J=1.9 Hz, 1H), 8.08 (s, 1H), 7.58-6.92 (m, 6H), 4.91 and 4.75 (rotamers, 2s, 2H), 3.09 and 2.91 (rotamers, 2s, 3H), 2.90 (m, 2H), 2.53, (m, 2H), 2.25 (s, 3H). MS (ESI): m/e 375 (M+H)+.
後処理
- filtrationThe resulting precipitate was collected by filtration
- washwashed with water
- customdried
- stirringstirred for 60 hours
- filtrationfiltered
- customdried
出典と根拠
- ORDレコード
- ord-e98d33029fdc47fa98c3609c0cc502a0
- 出典データセット
- uspto-grants-2013_05
- 特許番号
- US08450307B2
関連ノート
読み込み中…